REQUEST A DEMO
Total
USD $0.00
Search more companies

BioBlocks Magyarorszag Kft. (Hungary)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: BioBlocks Magyarorszag Kft. Profile Updated: September 26, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English & Hungarian Download a sample report

BioBlocks Magyarorszag Kft. is based in Hungary, with the head office in Budapest. It operates in the Pharmaceutical and Medicine Manufacturing sector. It was established on November 24, 2003. It currently has a total number of 17 (2024) employees. From the latest financial highlights, BioBlocks Magyarorszag Kft. reported a net sales revenue increase of 37.21% in 2024. During that time, BioBlocks Magyarorszag Kft.’s total assets grew by 33.32%.

Headquarters
Berlini ut 47-49.
Budapest; Budapest; Postal Code: 1045

Contact Details: Purchase the BioBlocks Magyarorszag Kft. report to view the information.

Website: http://www.bioblocks.hu

Basic Information
Total Employees:
Purchase the BioBlocks Magyarorszag Kft. report to view the information.
Registered Capital:
Purchase the BioBlocks Magyarorszag Kft. report to view the information.
Financial Auditors:
Purchase the BioBlocks Magyarorszag Kft. report to view the information.
Incorporation Date:
November 24, 2003
Key Executives
Purchase this report to view the information.
Managing Director
Purchase this report to view the information.
Manager
Ownership Details
Purchase this report to view the information.
Company Performance
Financial values in the chart are available after BioBlocks Magyarorszag Kft. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency HUF. Absolute financial data is included in the purchased report.
Net sales revenue
37.21%
Total operating revenue
30.63%
Operating profit (EBIT)
N/A
EBITDA
N/A
Net Profit (Loss) for the Period
N/A
Total Assets
33.32%
Total Equity
N/A
Operating Profit Margin (ROS)
N/A
Net Profit Margin
N/A
Return on Equity (ROE)
154.15%
Quick Ratio
1.46%
Cash Ratio
0.83%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?